The executive vice president of the neuroscience department at Rui Lai Company will retire.

Lilly Company announced that Anne White, the Executive Vice President of the Neuroscience Department, will retire at the end of this year, ending her thirty-year career with the company. She will continue in her position and as a member of the executive committee until December 31st, during which time the company will conduct internal and external searches to find her successor. Anne White has played a key role in shaping Lilly's research and development strategy, overseeing the launch of the company's first Alzheimer's treatment drug, and previously leading Lilly's Oncology division, guiding the acquisition of Loxo Oncology.